Acute Optic Neuritis

  • An-Guor Wang


A 25-year-old male presented with complaints of retrobulbar pain in both eyes starting about 1 week ago. The pain worsened with movement of the eyes in either direction. One day after onset, the left eye became blurred, and the patient subsequently visited an ophthalmologist and was told he had disc edema. He received oral steroids 5 mg tid. However, his symptoms persisted, and he was referred to us. Ophthalmic examination showed corrected acuity of 6/6 in the right eye and CF at 10 cm in the left. Full and free range of eye movement was noted. The patient could identify 15 plates OD and only 1 plate OS using the Ishihara color test. The anterior segment was normal in both eyes, but RAPD sign was positive for the left eye. Hyperemic disc with mild blurred margin was also found in his left eye (Fig. 1.1). OCT demonstrated left disc edema with increased thickness of the peripapillary retinal nerve fiber layer (RNFL) (Fig. 1.2). Under the impression of optic neuritis, he was admitted for further examination. The patient’s peripheral blood examination showed negative findings in autoimmune and/or infectious diseases. Two days post-admission, vision in the right eye deteriorated to CF, with only one plate according to the Ishihara test. Intact peripapillary and disc capillary was found at early phase of fluorescein angiography, with dye staining on disc at late phase (Fig. 1.3). The visual field was near totally obscured (Fig. 1.4). MR imaging showed increased thickness of both optic nerves with contrast enhancement (Fig. 1.5).


  1. 1.
    Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83–99.CrossRefPubMedGoogle Scholar
  2. 2.
    Loncarek K, Brajac I, Petricek I, Stalekar H, Cerovski B, Pokupe R. Epidemiology of monosymptomatic optic neuritis in Rijeka County, Croatia: meteorological aspects. Coll Antropol. 2005;29:309–13.PubMedGoogle Scholar
  3. 3.
    Swerdloff MA, Zieker AW, Krohel GB. Movement phosphenes in optic neuritis. J Clin Neuroophthalmol. 1981;1(4):279–82.PubMedGoogle Scholar
  4. 4.
    Fraser CL, Davagnanam I, Radon M, Plant GT. The time course and phenotype of Uhthoff phenomenon following optic neuritis. Mult Scler. 2012;18(7):1042–5.CrossRefPubMedGoogle Scholar
  5. 5.
    O’Doherty M, Flitcroft I. An unusual presentation of optic neuritis and the Pulfrich phenomenon. BMJ Case Rep. 2009;2009. pii: bcr08.2008.0647.Google Scholar
  6. 6.
    Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Arch Ophthalmol. 1991;109(12):1673–8.CrossRefGoogle Scholar
  7. 7.
    Sun MH, Wang HS, Chen KJ, WW S, Hsueh PY, Lin KK, Kao LY. Clinical characteristics of optic neuritis in Taiwanese children. Eye (Lond). 2011;25(11):1457–64.CrossRefGoogle Scholar
  8. 8.
    Optic Neuritis Study Group, Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Arch Ophthalmol. 1993;111:231–4.CrossRefGoogle Scholar
  9. 9.
    Kupersmith MJ, Alban T, Zeiffer B, Lefton D. Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain. 2002;125:812–22.CrossRefPubMedGoogle Scholar
  10. 10.
    Lin YC, Yen MY, Hsu WM, Lee HC, Wang AG. Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan. Jpn J Ophthalmol. 2006;50(2):170–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology. 1997;49(5):1404–13.CrossRefGoogle Scholar
  12. 12.
    Juryńczyk M, Craner M, Palace J. Overlapping CNS inflammatory diseases: differentiating features of NMO and MS. J Neurol Neurosurg Psychiatry. 2015;86(1):20–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Callen DJ, Shroff MM, Branson HM, Li DK, Lotze T, Stephens D, Banwell BL. Role of MRI in the differentiation of ADEM from MS in children. Neurology. 2009;72(11):968–73.CrossRefPubMedGoogle Scholar
  14. 14.
    Zhou L, Huang Y, Li H, Fan J, Zhangbao J, Yu H, Li Y, Lu J, Zhao C, Lu C, Wang M, Quan C. MOG-antibody associated demyelinating disease of the CNS: a clinical and pathological study in Chinese Han patients. J Neuroimmunol. 2017;305:19–28.CrossRefPubMedGoogle Scholar
  15. 15.
    Jarius S, Frederikson J, Waters P, et al. Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci. 2010;298:158–62.CrossRefPubMedGoogle Scholar
  16. 16.
    de Seze J, Arndt C, Jeanjean L, et al. Relapsing inflammatory optic neuritis: is it neuromyelitis optica? Neurology. 2008;70:2075–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008;70:2197–200.CrossRefPubMedGoogle Scholar
  18. 18.
    Akaishi T, Nakashima I, Takeshita T, Kaneko K, Mugikura S, Sato DK, Takahashi T, Nakazawa T, Aoki M, Fujihara K. Different etiologies and prognoses of optic neuritis in demyelinating diseases. J Neuroimmunol. 2016;299:152–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, Vucic S, Gorman MP, Benson LA, Alper G, Riney CJ, Barnett M, Parratt JD, Hardy TA, Leventer RJ, Merheb V, Nosadini M, Fung VS, Brilot F, Dale RC. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 2016;22(4):470–82.CrossRefPubMedGoogle Scholar
  20. 20.
    van Pelt ED, Wong YY, Ketelslegers IA, Hamann D, Hintzen RQ. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. Eur J Neurol. 2016;23(3):580–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol. 1993;111:773–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Matsuda R, Kezuka T, Umazume A, Okunuki Y, Goto H, Tanaka K. Clinical profile of anti-myelin oligodendrocyte glycoprotein antibody seropositive cases of optic neuritis. Neuroophthalmology. 2015;39(5):213–9.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63(7):964–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G, DeLuca G, Chandratre S, Leite MI, Vincent A, Palace J. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain. 2017;140(3):617–27.CrossRefPubMedGoogle Scholar
  25. 25.
    Beck RW, Cleary PA, Anderson MM Jr, et al. The Optic Neuritis Study Group. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 1992;326:581–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH. The Optic Neuritis Study Group. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med. 1993;329:1764–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Merle H, Olindo S, Jeannin S, Valentino R, Mehdaoui H, Cabot F, Donnio A, Hage R, Richer R, Smadja D, Cabre P. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol. 2012;130(7):858–62.CrossRefPubMedGoogle Scholar
  28. 28.
    Optic Neuritis Study Group. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology. 2008;115:1079–82.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • An-Guor Wang
    • 1
  1. 1.Department of OphthalmologyTaipei Veterans General Hospital, National Yang-Ming University School of Medicine, Yun-San Ophthalmology Education Research FoundationTaipeiTaiwan

Personalised recommendations